SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001737287-20-000027
Filing Date
2020-05-06
Accepted
2020-05-06 16:18:27
Documents
70
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q allo-20200331.htm   iXBRL 10-Q 1694489
2 EX-10.1 allo-2020331xex101.htm EX-10.1 178682
3 EX-31.1 allo-20200331xex311.htm EX-31.1 11479
4 EX-31.2 allo-20200331xex312.htm EX-31.2 11501
5 EX-32.1 allo-20200331xex321.htm EX-32.1 9733
11 allogenelogo1.jpg GRAPHIC 125971
12 allogenelogo2.jpg GRAPHIC 125971
13 allogenelogo3.jpg GRAPHIC 125971
14 allogenelogo4.jpg GRAPHIC 125971
15 allogenelogo5.jpg GRAPHIC 125971
16 image11.jpg GRAPHIC 413
  Complete submission text file 0001737287-20-000027.txt   7726430

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT allo-20200331.xsd EX-101.SCH 41606
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT allo-20200331_cal.xml EX-101.CAL 62153
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT allo-20200331_def.xml EX-101.DEF 212717
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT allo-20200331_lab.xml EX-101.LAB 534408
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT allo-20200331_pre.xml EX-101.PRE 335053
28 EXTRACTED XBRL INSTANCE DOCUMENT allo-20200331_htm.xml XML 1157911
Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Filer) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38693 | Film No.: 20852857
SIC: 2836 Biological Products, (No Diagnostic Substances)